Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction.

Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction.

OBJECTIVE: Galectin-3 (Gal-3) is a 26-kDa lectin known to regulate many aspects of inflammatory cell behavior. We assessed the hypothesis that increased levels of Gal-3 contribute to atherosclerotic plaque progression by enhancing monocyte chemoattraction through macrophage activation. METHODS AND...

Bibliográfalaš dieđut
Váldodahkkit:	Papaspyridonos, M, McNeill, E, de Bono, J, Smith, A, Burnand, K, Channon, K, Greaves, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2008

Geahča maid

A potential role for galectin-3 in atherosclerotic plaque progression through monocyte chemoattraction and macrophage activation
Dahkki: Papaspyridonos, M, et al.
Almmustuhtton: (2006)

A role for galectin-3 as an amplifier of inflammation in atherosclerotic plaque progression
Dahkki: Papaspyridonos, M, et al.
Almmustuhtton: (2007)

Tracking monocyte recruitment and macrophage accumulation in atherosclerotic plaque progression using a novel hCD68GFP/ApoE-/- reporter mouse
Dahkki: McNeill, E, et al.
Almmustuhtton: (2016)

Novel candidate genes in unstable areas of human atherosclerotic plaques.
Dahkki: Papaspyridonos, M, et al.
Almmustuhtton: (2006)

Single cell transcriptomics reveals how hyperlipidaemia alters monocyte/macrophage differentiation at sites of inflammation
Dahkki: Purvis, G, et al.
Almmustuhtton: (2020)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
Dahkki: Alessandro Corti, et al.
Almmustuhtton: (2020-02-01)

Ly6C hi Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation
Dahkki: Purvis, GSD, et al.
Almmustuhtton: (2024)

Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Dahkki: Bursill, C, et al.
Almmustuhtton: (2004)

Increased platelet reactivity is associated with circulating platelet-monocyte complexes and macrophages in human atherosclerotic plaques.
Dahkki: Bert Rutten, et al.
Almmustuhtton: (2014-01-01)

Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
Dahkki: White, G, et al.
Almmustuhtton: (2014)

Monocytic origin of foam cells in human atherosclerotic plaques.
Dahkki: Aqel, N, et al.
Almmustuhtton: (1984)

Ly6C<sup>hi</sup> Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation
Dahkki: Gareth S. D. Purvis, et al.
Almmustuhtton: (2024-05-01)

A new role for the regulator of G-protein signalling-1 (RGS-1) in the modulation of macrophage function in atherosclerosis
Dahkki: Patel, J, et al.
Almmustuhtton: (2010)

Assessment of serum levels of monocyte chemoattractant protein 1 (MCP 1) in patients with periodontitis and atherosclerotic cardiovascular disease
Dahkki: Safa A Hamad, et al.
Almmustuhtton: (2022-12-01)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
Dahkki: Max Lenz, et al.
Almmustuhtton: (2021-01-01)

Adenoviral-mediated delivery of a CC-chemokine inhibitor ('35K') attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
Dahkki: Bursill, C, et al.
Almmustuhtton: (2004)

CD74 in Apoptotic Macrophages Is Associated with Inflammation, Plaque Progression and Clinical Manifestations in Human Atherosclerotic Lesions
Dahkki: Wei Li, et al.
Almmustuhtton: (2022-01-01)

Adenoviral mediated delivery of a CC chemokine (CK) inhibitor ("35K") attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
Dahkki: Bursill, C, et al.
Almmustuhtton: (2004)

Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque
Dahkki: Sunny Goel, et al.
Almmustuhtton: (2015-01-01)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
Dahkki: Harald Mangge, et al.
Almmustuhtton: (2019-08-01)

The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability
Dahkki: Xiao-Bing Wu, et al.
Almmustuhtton: (2022-07-01)

Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy.
Dahkki: Abigail S Haka, et al.
Almmustuhtton: (2012-01-01)

Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm.
Dahkki: Qiwei Wang, et al.
Almmustuhtton: (2014-01-01)

PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages.
Dahkki: Louis de Léséleuc, et al.
Almmustuhtton: (2013-01-01)

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation
Dahkki: Hongxia Li, et al.
Almmustuhtton: (2022-03-01)

Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.
Dahkki: Xiao Ling Liu, et al.
Almmustuhtton: (2012-01-01)

A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture
Dahkki: Ramona Vinci, et al.
Almmustuhtton: (2021-10-01)

CD47-SIRPα signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques
Dahkki: Qing Xia, et al.
Almmustuhtton: (2024-10-01)

Tetrahydrobiopterin-dependent eNOS coupling attenuates vein graft atherosclerosis through inhibition of MCP-1 mediated monocyte recruitment to sites of vascular injury
Dahkki: Ali, Z, et al.
Almmustuhtton: (2007)

Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1.
Dahkki: Piotr Religa, et al.
Almmustuhtton: (2009-01-01)

Corrigendum: Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells
Dahkki: Teizo Yoshimura, et al.
Almmustuhtton: (2017-11-01)

MACROPHAGE POLARISATION IN SHEAR STRESS MODULATED ATHEROSCLEROTIC PLAQUE VULNERABILITY
Dahkki: Seneviratne, A, et al.
Almmustuhtton: (2012)

A lipid-structured model for macrophage populations in atherosclerotic plaques
Dahkki: Ford, HZ, et al.
Almmustuhtton: (2019)

Berberine activates macrophage autophagy and improves atherosclerotic plaque vulnerability
Dahkki: LIU Qin, YANG Li-xing, SHI Jing, HUANG Yu-qing, GAO Hong-ting, JU Rui, GUO Lei
Almmustuhtton: (2020-05-01)

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
Dahkki: Jeroen Baardman, et al.
Almmustuhtton: (2020-12-01)

Macrophage polarization and acceleration of atherosclerotic plaques in a swine model.
Dahkki: Seul-Gee Lee, et al.
Almmustuhtton: (2018-01-01)

Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages.
Dahkki: Cansu Yıldırım, et al.
Almmustuhtton: (2015-01-01)

Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma
Dahkki: Melanie Erriah, et al.
Almmustuhtton: (2019-01-01)

The role of tetrahydrobiopterin in inflammation and cardiovascular disease.
Dahkki: McNeill, E, et al.
Almmustuhtton: (2012)

Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo.
Dahkki: Iqbal, A, et al.
Almmustuhtton: (2014)